ABSTRACT. In order to elucidate the mechanism controlling the biogenesis of the Golgi complex, we have studied whether the expression of a resident membrane protein p138 of the Golgi complex is dependent upon the cell cycle. The protein level of p138 in human KB cells was increased during thymidine block to synchronize the cells in the early-S phase, but changed little from S to G2 after release from the block. On the other hand, the mRNA level of the p138 gene was constant during the block. The change in mRNA level in the cells was small with a low peak at S to G2. Both p138 protein and mRNA levels decreased after cell division and then rose rapidly to the same level as those of log-phase cells in the next G1 to S. Thus, translation of p138 protein was upregulated in the cells at the early-S phase. However, we found also that the p138 protein level increased during an arrest at G2/M caused by etoposide. The kinetics of centrosome duplication apparently differ from those of p138 protein production. The duplication occurred mainly at S to G2 after the release from thymidine block, while the ratio of cells containing duplicated centrosomes increased gradually during the block. Taken together, these results show that both the translation and transcription of p138 protein are regulated independent of the cell cycle and dissociated from the duplication of the centrosome. Rather, the expression of p138 protein seems to be coupled with a change in cell size since both thymidine block and etoposide inhibition resulted in an apparent increase in cell size.
When a cell divides, each daughter cell usually receives a complete set of cellular components. Presumably there is a specific mechanism controlled in some way by the cell replication cycle or growth regulation for maintaining the quantity of cell organelles. Much of the information available on the replication of nuclei and centrosomes indicates that these organelles are under the control of the Cdc cycle (Heald and McKeon, 1990; Pfaller et al., 1991; Hinchcliffe et al., 1999) . On the other hand, the proliferation of other organelles such as the ER, mitochondria and peroxisomes is achieved by transcriptional networks of genes encoding organellar proteins that respond to changes in demand for the function of a particular organelle (Nunnari and Walter, 1996) .
The Golgi complex is the site of divergence of the intracellular transport routes involved in the export of proteins from the ER suggesting an intimate correlation of their biogenesis. On the other hand, the Golgi complex undergoes dramatic structural modification as the cell cycle progresses. When cells enter the mitotic phase, the Golgi apparatus becomes fragmented and dispersed throughout the cytoplasm (Zeligs and Wollman, 1979) . This fragmentation during mitosis ensures equal partitioning of the organelle to the two daughter cells (Lucocq and Warren, 1987) . The Golgi complex is located in a circumscribed juxtanuclear region where the microtubule-organizing center (MTOC) is localized (Thyberg and Moskalewski, 1985) . The MTOC has a role in maintaining the integrity and location of the Golgi complex in interphase cells through microtubules (Hoshino et al., 1997) . The duplication of the centrosome, a major MTOC in eukaryotic cells (Bornens, 1992) , begins near the G1-S boundary and is completed in G2 (Vandre and Borisy,
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Thus, two alternative possibilities exist for the regulation of the biogenesis of the Golgi complex; it is either under cell cycle control coupled with centrosome duplication, or changes in the environment of a cell to modulate the biogenesis essentially independent of the cell cycle.
Little is known, however, about the regulation and timing of biogenesis of the Golgi complex during the cell cycle. Answers to these questions might provide new approaches to the study of the maintenance and duplication of cell organelle. We hypothesized that by using an appropriate protein as a marker of the duplication of Golgi complex, we would be able to monitor the process by measuring the changes in the quantity of the protein. We have obtained an antibody against a Golgi resident membrane protein, p138 (Yamauchi et al., 1992) , and showed that it was useful as a Golgi marker during M phase (Asada and Yagura, 1995) . The p138 protein appears to be identical to the Golgi integral membrane protein GPP130 (Linstedt et al., 1997) as revealed by the analysis of cDNA clones. Using p138 as a marker, we determined the changes in the protein and mRNA levels during cell cycle progression. The results obtained using the double thymidine block procedure and the inhibition by a topoisomerase II inhibitor, etoposide (VP-16), indicate that the biogenesis of the Golgi complex is accompanied by an increase in cell size rather than a change in the cell cycle.
Materials and Methods

Antibodies and drug
Hybridoma cell line (mAbG3A5) that secretes monoclonal antibody against p138 protein of human origin was prepared as described earlier (Yamauchi et al., 1992) . Rabbit antibodies to cyclin B1 and Cdc 2 were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). FITC-conjugated antibodies were purchased from Dako Ltd. Autoimmune human serum reactive against centrosome was kindly supplied by Medical & Biological Laboratories Co., Ltd., Nagoya, Japan. Etoposide (VP-16) was obtained from Sigma.
Synchronization and Flow Cytometric Analysis (FACScan analysis) of DNA and p138 protein contents
Synchronous KB cell populations were obtained by double thymidine treatment as described previously (Ishida et al., 1994) . Cells in an exponential phase of growth in Eagle's minimum essential medium supplemented with 10% fetal calf serum were treated with 2 mM thymidine for 24 h, rinsed and recultivated in drug-free medium for 12 h, and then treated with thymidine (2 mM) again. After 24 h (second block), the thymidine block was released by rinsing, and the cells were cultured in drug-free medium. At specified times, cultures were harvested using EDTA and fixed in 70% ethanol. Cells were first treated with RNase A at 100 µg/ml and then stained with propidium iodide (10 µg/ml in phosphatebuffered saline) before analysis using a FACS flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA). Data were acquired from 10 4 cells, and the fraction of cells in each phase of the cell cycle was calculated using software developed by the flow cytometer's manufacturer.
Simultaneous measurement of DNA content (as an indicator of the cell cycle) and p138 protein content (as an indicator of the mass of the Golgi complex) was carried out by double staining of the cells with propidium iodide and fluorescein isothiocyanate, followed by an analysis of the cells by flow cytometry. KB cells were harvested by EDTA treatment and fixed in 1% paraformaldehyde at 4°C for 1 h. Fixed cells were washed once with PBS, permeabilized with 0.5% Triton-X for 10 min, washed once with PBS, and treated with anti-p138 antibody (mAbG3A5) and RNase A at 50 µg/ml for 2 h at room temperature. Cells were then washed with PBS, labeled with FITC-conjugated rabbit anti-mouse secondary antibody, and counterstained with propidium iodide at 10 µg/ml for 20 min. Samples were again washed with PBS, resuspended at 10 5 cells/ml, and analyzed using a FACS flow cytometer. Multivariate analysis was used for the simultaneous determination of cellular p138 protein content measured as fluorescence and cell cycle phase measured as propidium iodide fluorescence (DNA content).
RNA analysis
Total cellular RNA was isolated from cell cultures using a QuickPrep Total RNA Extraction Kit (Pharmacia Biotech), and the quantification of mRNA sequences was performed with a real-time PCR detection procedure and a system 7700 (Applied Biosystems, Inc.) according to the manufacturer's directions. The values were calibrated with the rRNA content as an internal standard.
Western blot (immunoblot) analysis
For immunoblotting, total cellular protein was solubilized in Laemmli's buffer (Laemmli, 1970) , separated by one-dimensional electrophoresis on SDS-8% polyacrylamide gels and blotted onto Immobilon P membranes. Proteins of interest were detected using specific antibodies as described previously (Hoshino et al., 1997) . The levels of each protein on the blots were determined using Scion Image software.
Measurement of cell size
KB cells cultured and treated with thymidine or etoposide on cover glasses were washed once with PBS, and then treated with 20% ethanol containing 0.5% crystal violet. After washing with PBS, stained cells were viewed under an Olympus microscope and images were taken with a digital camera. The cell size was determined from the images using Scion-image software.
Results
The p138 protein appears to be identical to human Golgi integral membrane protein GPP130
We have obtained cDNA clones encoding p138 protein purified from HeLa cells using a specific monoclonal antibody, mAbG3A5 (Yamauchi et al., 1992) . The amino acid sequence predicted from the cDNAs matched exactly that of the Golgi integral membrane protein GPP130 reported by Linstedt (Linstedt et al., 1997) (data not shown). The p138/ GPP130 protein is a type 2 resident protein of the cis and medial Golgi membrane (Asada and Yagura, 1995; Linstedt et al., 1997) . Thus, the p138 protein can be used as a marker of the Golgi complex (Asada and Yagura, 1995; Hoshino et al., 1997) . Fig. 1 . p138 protein levels in log-phase KB cells. Log-phase KB cells were analyzed by FACScan after staining with mAbG3A5 for p138 protein and PI for DNA as described in Materials and Methods (A). The horizontal axis of the panels represents the relative level of p138 protein content based on fluorescence intensity. The vertical axis represents the DNA content of the cells. In B, C and D, the distribution of p138-labeled fluorescence intensity was plotted for the gated areas as indicated in (A) versus cell number.
Measurement of the p138 protein content in individual cells during the cell cycle by FACScan analysis
To obtain information about the p138 protein content per cell during each phase of the cell cycle, we double-labeled the protein and DNA and examined their amounts by FACScan analysis. First, to determine when in the cell cycle the level of protein increased, we examined mid-log phase cultures (Fig. 1) . KB cells in mid-log phase were divided into three groups according to DNA content (2c (G1), intermediate (S), 4c (G2 and M)). Figs. 1B-D show that the p138 protein content per cell, which was detected using the mAbG3A5 antibody, increased markedly from S to G2.
Changes in the p138 protein level during the cell cycle
To determine exactly when the Golgi complex is duplicated during the cell cycle, we performed Western blot analyses of the change in the protein level of p138 as well as cyclin B1 and Cdc 2 as references in extracts of human KB cells synchronized by thymidine block (Fig. 2A) . The Cdc 2 content did not change during the cell cycle, while the amount of cyclin B1, a marker of late G2/early M cells, fluctuated indicating that the cell cycle progressed normally. Thus, to compare the protein levels of p138 in cells during cell cycle, they were normalized to the Cdc 2 levels of the same cell extracts. The p138 protein content was already increased about two-fold at the time of the release (time 0) compared with the level in the log-phase culture (RAN) (Fig. 2B ). After remaining relatively constant during S, G2 and M (5-12 h), the protein level decreased in G1 (19 h), indicating that p138 was distributed to each daughter cell. Then, production of the protein resumed in the next S phase (24 h).
The results shown in Fig. 2 indicate that the cells at time 0 of synchronization already had more p138 than the cell in random culture. To determine when the p138 protein increased, Western blot analysis was performed to examine changes in the protein level during thymidine block. Fig. 3 shows that an increase was induced during the second Fig. 2 . Western blot analysis of the change in p138 protein level during the cell cycle. KB cells were synchronized in early S by double thymidine block as described under Materials and Methods. Samples of the cells were taken at the times indicated above each lane after release. (A) Whole-cell extracts (1×10 5 cells) were then prepared in SDS loading buffer, and the proteins were resolved by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes. Western immunoblotting was performed as described under Materials and Methods. The blots were incubated with mAbG3A5, anti-Cdc2 or anti-cyclin B1, respectively and then incubated with alkaline phosphatase-conjugated secondary antibody. The cell cycle stage of each sample is shown above the lane. (B) The ratio between the p138 protein and Cdc2 level is plotted against time after release. The values were normalized relative to that in a log-phase culture (RAN). Each bar represents the average ±s.e.m. of triplicate determinations. The cell cycle progression was monitored by FACS analysis and the cell cycle phase of each sample was determined as shown in Fig. 4 : 0-5 h, S; 8 h, S/G2; 12 h, G2/M; 19 h, G1; 24 h, second S. Fig. 3 . p138 protein accumulated during the second thymidine block during synchronization. KB cells were treated with excess thymidine as described under Materials and Methods. Samples of the cells were taken during the second round of thymidine block at 0 h and then at 6-h intervals. Whole-cell extracts were prepared in SDS loading buffer, and the proteins were resolved by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes. Western immunoblotting was performed as described in the legend to Fig. 2 . Each bar represents the average ±s.e.m. of triplicate determinations. thymidine block. As cells in the early-S phase were abundant during the thymidine block (Ishida et al., 1994; Whitfield et al., 2000) , these results indicated that the expression of p138 protein is upregulated in early-S.
Next, the changes in the mass distribution of cells with different DNA and p138 contents were analyzed by FACScan at different times after the release from double thymidine block (Fig. 4) . At time 0 after the release, many 2c cells rich in p138 protein appeared, whereas such cells constituted only a small fraction of the population in the log-phase culture (compare Figs. 1A and 4A) consistent with the increased p138 protein content of cells during thymidineblock as shown in Fig. 3 . Thereafter, the cells with a high p138 protein content shifted to the S (8 h) and G2 (12 h) cell groups. This change in p138 content per cell was consistent with the results of Western blot analysis shown in Fig. 2 . Thus, we confirmed that the p138 protein is produced during the early-S phase of the cell cycle in the case of thymidine block experiment.
The p138 protein level also increased in cells arrested at G2 by the topoisomerase II-specific inhibitor, etoposide
The results obtained from the culture synchronized by the thymidine block indicate an increase in the protein level of p138 during the early-S phase. However, we could not clarify whether the protein level increased in other phases, especially at G2 because overproduction of the protein during the block in the early-S phase obscured any subsequent small changes in the protein level. We therefore used the specific topoisomerase II inhibitor etoposide (VP-16) (D'Arpa and Liu, 1989). Topoisomerase II inhibitors are known to arrest human cells in G2 (Kalwinsky et al., 1983; Tobey, 1975; Krishan et al., 1975; Tobey et al., 1990) . Fig.  5 shows the distribution of p138 protein in 4C DNA cells arrested in G2 at various time points after the administration 5 . Changes in the p138 protein content of 4C KB cells during etoposide treatment. KB cells were collected at different time points after the addition of etoposide (1 µg/ml culture medium) and were processed for FACS analysis after staining with mAbG3A5 for p138 protein and PI for DNA as in Fig. 1 . Populations of KB cells within the 4C DNA gate at 0 h (control, dotted line), 12 h (fine line) and 24 h (bold line) were measured for p138 protein content. This analysis shows that the protein content per 4C cell gradually increased with incubation during the G2/M block with etoposide. of etoposide. It is obvious that the protein content per 4C cell gradually increased with time after the treatment. Western blot analysis confirmed this result; Fig. 6B shows that the p138 level is increased in cells arrested at G2. At this time, the protein level of cyclin B also increased indicating the cells to be at late G2 (Fig. 6A) . Thus, the results indicate that p138 protein was also produced in G2-blocked cells.
Changes in the level of p138 mRNA during the cell cycle
To determine how the expression of p138 protein is regulated in the early-S phase and the G2, the level of p138 mRNA was measured using a real-time PCR detection procedure. The mRNA levels were normalized to the rRNA levels because it was difficult to absolutely eliminate variations in the efficiency of mRNA recovery. Fig. 7 shows the changes in the mRNA level of p138 at different times after the release from the double thymidine block. The level was relatively constant through S to M with a small peak at S/G2, while the level of cyclin B1 mRNA increased in G2 and M (data not shown). The p138 mRNA level decreased thereafter at G1 after the cytokinesis and then increased again in the next S phase (24 h). Interestingly, the mRNA level did not increase during the thymidine block (compare time 0 with the random culture in Fig. 7 ) in spite of a significant increase in protein (see time 0 of Fig. 2B ). Thus, it appears that no significant upregulation in the transcription of the p138 mRNA occurs during the thymidine block.
p138 protein expression dissociated from centrosome duplication
The Golgi complex is located in a circumscribed juxtanuclear region where the microtubule-organizing center (MTOC) is localized (Thyberg and Moskalewski, 1985) . The duplication of the centrosome, a major MTOC in eukaryotic cells (Bornens, 1992) , begins at around the G1-S and is completed in G2 (Vandre and Borisy, 1989) . In G2 cells, mother and daughter centrioles replicated at the G1/S transition separate to make two MTOCs to which the Golgi complex localizes (Piel et al., 2000) . The time course of this duplication seems to coincide with that of the upregulation of p138 protein production. Then, to investigate the possibility that the duplication of MTOC affects the level of p138 protein, we examined the time course of centrosome duplication during and after thymidine treatment and compared it with the changes in p138 protein levels. As shown in Fig. 8,   Fig. 6 . Western blot analysis of the change in p138 protein level during etoposide treatment. KB cells were treated in medium containing etoposide (1 µg/ml), collected and pooled at different times. (A) Whole-cell extracts (1×10 5 cells) were then prepared in SDS loading buffer and the proteins were resolved by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes. Western immunoblotting with mAbG3A5, anti-Cdc2 or anti-cyclin B1 was performed as described for Fig. 2 legend. (B) Ratios between the p138 protein and Cdc2 levels are plotted against time after addition of etoposide. The values were normalized relative to that in a log-phase culture (0 h). Each bar represents the average ±s.e.m. of triplicate determinations. Fig. 7 . Changes in the level of p138 mRNA during the cell cycle. KB cells were synchronized with the double thymidine procedure and total RNA was prepared at the times indicated after release. Five micrograms of total RNA was analyzed for p138 mRNA using a real-time PCR detection procedure. Ribosomal RNA and Cdc 2 mRNA were simultaneously measured as internal standards. The cell cycle progression was monitored by FACS analysis and the phase of each cell sample was determined. Each bar represents the average ±s.e.m. of triplicate determinations.
the percentage of cells with a duplicated centrosome increased but was no more than 30% during the second thymidine block, while the centrosome was rapidly copied afterward (at S to G2). The p138 protein overexpressed during the thymidine block was found to be distributed solely to the Golgi complex when examined by a cytochemical method. These results suggest that the duplication of the Golgi complex is not coupled with the duplication of the centrosome.
Arrest in the early S phase by thymidine and at G2/M by etoposide resulted in an increase in cell size
We addressed the biological significance of the increase in p138 protein in the early-S-blocked and G2-blocked cells. The abundance of certain subcellular compartments is altered by changes in the metabolic state (Nunnari and Walter, 1996) . Previously it was shown that several reagents which inhibit the cell cycle cause an increase in cell mass at a subtoxic concentration (Doering et al., 1966; Pérez et al., 1997) . Then, we examined the changes in cell size during the block by thymidine and etoposide. As shown in Fig. 9 , both treatments induced an increase in cell size. The time course of the change in the rate of the increase roughly coincided with that of the p138 protein level in each case (see Figs. 3 and 6) . Thus, the production of p138 protein during the blocks seems to be constitutive and associated with an increase in cell size not with cell cycle progression.
Discussion
In this study, we examined how the expression of p138 protein is regulated during the cell cycle. FACScan analysis of log-phase cultures indicated that the protein level increased from S to G2 of the cell cycle. In contrast, Western immunoblot analysis showed no significant upregulation in the production of p138, compared with that at time after the cells were released from the thymidine block, in spite that cyclin B1 expression changed as the cell cycle progressed. In the same experiment, the p138 protein level was found to be about two-fold higher at the time of the release (time 0) than in the log-phase of the culture. In order to clarify the situation, cells were removed at intervals during the thymidine block and tested for p138 protein. We found a significant Fig. 8 . Time course of centrosome duplication during the thymidine block (A) and after release from the block (B). One part of the KB cell culture was treated with thymidine for synchronization and processed for immunofluorescence microscopy using anticentrosome human autoimmune serum at the times indicated (A). Another part of the culture was processed for immunofluorescence microscopy at the times indicated after release from thymidine block (B). Not more than 5% of KB cells of the log-phase culture contained two separated centrosomes. In G2 cells, mother and daughter centrosomes are separated sufficiently to be observed under immunofluorescence microscope. Each bar represents the average ±s.e.m. of triplicate determinations. increase in protein content during the block. This indicates that cells in the early-S phase have high levels of p138 protein because an excess of thymidine blocked the cells in this phase. Moreover, we found the production of protein to be upregulated during treatment with a G/M inhibitor. Thus, the cells in early-S and G2 accumulate p138 protein. However, the amount of p138 per cell seemed to be limited as indicated by the constant level from S to G2 after the release from the block. This cannot be ascribed to a degradation of the protein because the half-life of p138 is quite long (20 h) (Yuan et al., 1987) and we did not detect any increase in degradation during the S phase by preliminary experiments. The most straightforward interpretation of these results is that the production of p138 proteins is coupled with the duplication of the centrosome in connection with the biogenesis of the Golgi complex. The duplication of the centrosome, which is a major MTOC in eukaryotic cells (Bornens, 1992) begins around the G1-S boundary and is completed in G2 (Vandre and Borisy, 1989) . Then, it is possible that the centrosome was replicated and separated to make two centrosomes during the second thymidine block when p138 protein was overproduced. However, as shown in Fig. 6 , the increase in the p138 protein level was not necessarily coupled with the centrosome duplication since the most important part of the centrosome did not begin to separate until after the release of the thymidine block.
We showed that a significant amount of p138 mRNA is present at each phase of the cell cycle. The fact that the amount of p138 protein increased during the block with excess thymidine in spite of a lack of apparent change in the mRNA level, indicates that a constitutive translation of p138 protein occurred throughout the cell cycle except in the M phase. This constitutive translation might be necessary to maintain the structural integrity of the Golgi complex. On the other hand, the increase in protein in the second S phase suggests that the Golgi complex was copied during this period in log-phase culture. Organelles usually form via the proliferation of preexisting organelles. Upon demand for the function of a particular organelle, an appropriate modulation of the expression of genes encoding organelle proteins occurs resulting in a proliferation of the organelle (Nunnari and Walter, 1996) . In peroxisomes and the ER, this type of regulation has been studied extensively using Saccharomyces cerevisiae (Einerhand et al., 1992; Cox et al., 1993) . Nevertheless, neither the cell cycle progression nor the centrosome duplication correlated directly with this increase in p138 protein. This might be true for the proliferation of Golgi complexes because the p138 protein is a good marker of the Golgi complex membrane system. What then is the cause of the increase in p138 protein in the blocked cells? Treatment with excess thymidine for cell synchronization left the cells with an early-S DNA content while their protein content increased at the same rate as in untreated cells resulting in an enlargement of the cells (a state of unbalanced growth) (Anderson et al., 1967) . In the present study, we showed that cell size increased during the cell cycle block at early-S and G2/M (ca. two-fold increase, see Fig. 9 ). Based on this observation, we concluded that the level of p138 protein is regulated by cell mass at the translational level, perhaps through the regulation of the number of Golgi complexes. The membrane system is shared by the Golgi complex and ER. Thus, any alteration to the ER may result in a change in the biogenesis of the Golgi complex. To better understand the mechanism of the biogenesis of the Golgi complex, we are presently examining the possibility that it is affected by the biogenesis of the ER.
